Citigroup’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.37M Sell
13,604
-163
-1% -$35.1K ﹤0.01% 2490
2026
Q1
$2.76M Sell
13,767
-73
-0.5% -$15.1K ﹤0.01% 2441
2025
Q4
$2.86M Buy
13,840
+1,002
+8% +$200K ﹤0.01% 2418
2025
Q3
$2.3M Buy
12,838
+677
+6% +$115K ﹤0.01% 2562
2025
Q2
$1.96M Sell
12,161
-453
-4% -$72.2K ﹤0.01% 2664
2025
Q1
$2.15M Sell
12,614
-1,872
-13% -$325K ﹤0.01% 2636
2024
Q4
$2.41M Sell
14,486
-4,576
-24% -$782K ﹤0.01% 2657
2024
Q3
$3.28M Sell
19,062
-1,045
-5% -$173K ﹤0.01% 2215
2024
Q2
$3.1M Buy
20,107
+4,564
+29% +$685K ﹤0.01% 1996
2024
Q1
$2.39M Buy
15,543
+3,121
+25% +$476K ﹤0.01% 2296
2023
Q4
$1.96M Sell
12,422
-1,552
-11% -$223K ﹤0.01% 2254
2023
Q3
$2.05M Buy
13,974
+1,607
+13% +$245K ﹤0.01% 1964
2023
Q2
$1.89M Buy
12,367
+224
+2% +$34.9K ﹤0.01% 2268
2023
Q1
$1.88M Sell
12,143
-561
-4% -$88.1K ﹤0.01% 2062
2022
Q4
$1.96M Sell
12,704
-3,008
-19% -$444K ﹤0.01% 2055
2022
Q3
$2.07M Sell
15,712
-911
-5% -$128K ﹤0.01% 2115
2022
Q2
$2.25M Sell
16,623
-772
-4% -$106K ﹤0.01% 2019
2022
Q1
$2.59M Buy
17,395
+33
+0.2% +$4.88K ﹤0.01% 2154
2021
Q4
$2.81M Buy
17,362
+842
+5% +$136K ﹤0.01% 2332
2021
Q3
$2.74M Sell
16,520
-8,470
-34% -$1.45M ﹤0.01% 2284
2021
Q2
$4.31M Buy
24,990
+493
+2% +$81.4K ﹤0.01% 2022
2021
Q1
$3.93M Buy
24,497
+798
+3% +$137K ﹤0.01% 1968
2020
Q4
$3.98M Buy
23,699
+1,655
+8% +$268K ﹤0.01% 2257
2020
Q3
$3.47M Sell
22,044
-522
-2% -$85.3K ﹤0.01% 2172
2020
Q2
$3.79M Buy
22,566
+522
+2% +$81.9K ﹤0.01% 2126
2020
Q1
$2.89M Sell
22,044
-2,049
-9% -$292K ﹤0.01% 2134
2019
Q4
$3.58M Sell
24,093
-2,957
-11% -$406K ﹤0.01% 2338
2019
Q3
$3.35M Sell
27,050
-1,742
-6% -$232K ﹤0.01% 2313
2019
Q2
$4.05M Buy
28,792
+2,399
+9% +$331K ﹤0.01% 2154
2019
Q1
$3.98M Buy
26,393
+868
+3% +$125K ﹤0.01% 1990
2018
Q4
$3.17M Buy
25,525
+2,263
+10% +$309K ﹤0.01% 2254
2018
Q3
$3.69M Buy
23,262
+5,178
+29% +$784K ﹤0.01% 2154
2018
Q2
$2.53M Buy
18,084
+1,800
+11% +$247K ﹤0.01% 2482
2018
Q1
$2.16M Buy
16,284
+3,087
+23% +$421K ﹤0.01% 2521
2017
Q4
$1.64M Buy
13,197
+987
+8% +$122K ﹤0.01% 2867
2017
Q3
$1.51M Buy
12,210
+1,865
+18% +$221K ﹤0.01% 2944
2017
Q2
$1.18M Buy
10,345
+718
+7% +$77.2K ﹤0.01% 3136
2017
Q1
$1.01M Buy
9,627
+5,753
+149% +$577K ﹤0.01% 3195
2016
Q4
$352K Buy
3,874
+669
+21% +$62.7K ﹤0.01% 4749
2016
Q3
$320K Buy
3,205
+60
+2% +$5.89K ﹤0.01% 4296
2016
Q2
$281K Sell
3,145
-3,825
-55% -$351K ﹤0.01% 4188
2016
Q1
$611K Sell
6,970
-22,584
-76% -$1.99M ﹤0.01% 3908
2015
Q4
$3.34M Buy
29,554
+3,756
+15% +$404K ﹤0.01% 2067
2015
Q3
$2.61M Buy
25,798
+5,355
+26% +$637K ﹤0.01% 2221
2015
Q2
$2.54M Buy
20,443
+8,978
+78% +$1.08M ﹤0.01% 2311
2015
Q1
$1.36M Buy
11,465
+6,463
+129% +$731K ﹤0.01% 2822
2014
Q4
$510K Buy
5,002
+2,900
+138% +$283K ﹤0.01% 3869
2014
Q3
$193K Buy
2,102
+359
+21% +$31.1K ﹤0.01% 4266
2014
Q2
$144K Buy
1,743
+342
+24% +$26.1K ﹤0.01% 4393
2014
Q1
$107K Sell
1,401
-1,488
-52% -$116K ﹤0.01% 4925
2013
Q4
$200K Buy
2,889
+196
+7% +$12.9K ﹤0.01% 4657
2013
Q3
$175K Buy
2,693
+2,276
+546% +$144K ﹤0.01% 4267
2013
Q2
$24K Buy
+417
New +$23.8K ﹤0.01% 5744

Other funds holding FBT

Citigroup's FBT Position: Q2 2026 in Review

Citigroup reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.2% in Q2 2026, selling an estimated $35.1K and leaving 13,604 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Citigroup first reported a position in FBT in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.31M in Q2 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Citigroup held 13,604 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.37M as of Q2 2026.
  • Citigroup sold 163 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $35.1K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2490 holding.
  • Citigroup first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 53 quarters since.
  • Citigroup's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.31M in Q2 2021.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.